A
American Oncology Partners | The Center for Cancer & Blood Disorders - Bethesda
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Pembrolizumab
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 3 total trials
Immune therapies work with the body's immune system to treat a number of cancers. They work with T-cells, a type of white blood cell, to target and a...
Enrolling
Advanced Solid Tumors
Drug: Docetaxel
Drug: pembrolizumab
A Randomized, Double-blind, Multi-center, Phase III Clinical Study of AK112 or Placebo Combined With Pemetrexed and Carboplatin in Patients With EGFR...
Active, not recruiting
Non-Squamous Non-small Cell Lung Cancer
Drug: Placebo Injection
Drug: Ivonescimab (SMT112 or AK112) Injection
A Randomized, Double-blind, Multi-center, Phase III Clinical Study of AK112 or Placebo Combined With Pemetrexed and Carboplatin in Patients With EGFR...
Active, not recruiting
Non-Squamous Non-small Cell Lung Cancer
Drug: Placebo Injection
Drug: AK112 Injection
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems